Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:11985620rdf:typepubmed:Citationlld:pubmed
pubmed-article:11985620lifeskim:mentionsumls-concept:C0034721lld:lifeskim
pubmed-article:11985620lifeskim:mentionsumls-concept:C0034693lld:lifeskim
pubmed-article:11985620lifeskim:mentionsumls-concept:C0028128lld:lifeskim
pubmed-article:11985620lifeskim:mentionsumls-concept:C0026844lld:lifeskim
pubmed-article:11985620lifeskim:mentionsumls-concept:C1135918lld:lifeskim
pubmed-article:11985620lifeskim:mentionsumls-concept:C0021745lld:lifeskim
pubmed-article:11985620lifeskim:mentionsumls-concept:C0033634lld:lifeskim
pubmed-article:11985620lifeskim:mentionsumls-concept:C0041904lld:lifeskim
pubmed-article:11985620lifeskim:mentionsumls-concept:C0033268lld:lifeskim
pubmed-article:11985620lifeskim:mentionsumls-concept:C0205263lld:lifeskim
pubmed-article:11985620lifeskim:mentionsumls-concept:C2349975lld:lifeskim
pubmed-article:11985620lifeskim:mentionsumls-concept:C1627358lld:lifeskim
pubmed-article:11985620pubmed:issue9lld:pubmed
pubmed-article:11985620pubmed:dateCreated2002-5-2lld:pubmed
pubmed-article:11985620pubmed:abstractTextThe effect of alpha-tocopheryl hemisuccinate (TS) on lipopolysaccharide (LPS)/interferon-gamma (IFN)-induced nitric oxide production in rat vascular smooth muscle cells (VSMC) was examined. The LPS/IFN-induced NO production was enhanced by TS but not by the other alpha-tocopherol (alpha-T) derivatives alpha-tocopheryl acetate (TA) and alpha-tocopheryl nicotinate (TN), or alpha-T itself. alpha-T, TA and TN inhibited the enhancement by TS of LPS/IFN-induced NO production. The enhancing effect of TS was observed in the presence of LPS, but not IFN, suggesting that TS participates in the LPS-stimulated signal pathway leading to NO production. Protein kinase C (PKC) inhibitors, but not protein kinase A inhibitors, inhibited the enhancing effect of TS on LPS/IFN-induced NO production. Furthermore, TS enhanced the amount of PKCalpha in VSMC. From these results, we concluded that the enhancing effect of LPS/IFN-induced NO production was caused by upregulation of PKC in VSMC.lld:pubmed
pubmed-article:11985620pubmed:languageenglld:pubmed
pubmed-article:11985620pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11985620pubmed:citationSubsetIMlld:pubmed
pubmed-article:11985620pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11985620pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11985620pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11985620pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11985620pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11985620pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11985620pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11985620pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11985620pubmed:statusMEDLINElld:pubmed
pubmed-article:11985620pubmed:monthMaylld:pubmed
pubmed-article:11985620pubmed:issn0014-2956lld:pubmed
pubmed-article:11985620pubmed:authorpubmed-author:AraMMlld:pubmed
pubmed-article:11985620pubmed:authorpubmed-author:TokumuraAkira...lld:pubmed
pubmed-article:11985620pubmed:authorpubmed-author:KogureKentaro...lld:pubmed
pubmed-article:11985620pubmed:authorpubmed-author:FukuzawaKenji...lld:pubmed
pubmed-article:11985620pubmed:authorpubmed-author:HamaSusumuSlld:pubmed
pubmed-article:11985620pubmed:authorpubmed-author:NakashimaSawa...lld:pubmed
pubmed-article:11985620pubmed:issnTypePrintlld:pubmed
pubmed-article:11985620pubmed:volume269lld:pubmed
pubmed-article:11985620pubmed:ownerNLMlld:pubmed
pubmed-article:11985620pubmed:authorsCompleteYlld:pubmed
pubmed-article:11985620pubmed:pagination2367-72lld:pubmed
pubmed-article:11985620pubmed:dateRevised2008-11-21lld:pubmed
pubmed-article:11985620pubmed:meshHeadingpubmed-meshheading:11985620...lld:pubmed
pubmed-article:11985620pubmed:meshHeadingpubmed-meshheading:11985620...lld:pubmed
pubmed-article:11985620pubmed:meshHeadingpubmed-meshheading:11985620...lld:pubmed
pubmed-article:11985620pubmed:meshHeadingpubmed-meshheading:11985620...lld:pubmed
pubmed-article:11985620pubmed:meshHeadingpubmed-meshheading:11985620...lld:pubmed
pubmed-article:11985620pubmed:meshHeadingpubmed-meshheading:11985620...lld:pubmed
pubmed-article:11985620pubmed:meshHeadingpubmed-meshheading:11985620...lld:pubmed
pubmed-article:11985620pubmed:meshHeadingpubmed-meshheading:11985620...lld:pubmed
pubmed-article:11985620pubmed:meshHeadingpubmed-meshheading:11985620...lld:pubmed
pubmed-article:11985620pubmed:meshHeadingpubmed-meshheading:11985620...lld:pubmed
pubmed-article:11985620pubmed:meshHeadingpubmed-meshheading:11985620...lld:pubmed
pubmed-article:11985620pubmed:meshHeadingpubmed-meshheading:11985620...lld:pubmed
pubmed-article:11985620pubmed:year2002lld:pubmed
pubmed-article:11985620pubmed:articleTitleEnhancement by alpha-tocopheryl hemisuccinate of nitric oxide production induced by lypopolysaccharide and interferon-gamma through the upregulation of protein kinase C in rat vascular smooth muscle cells.lld:pubmed
pubmed-article:11985620pubmed:affiliationFaculty of Pharmaceutical Sciences, University of Tokushima, Japan.lld:pubmed
pubmed-article:11985620pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:11985620pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed